Novel Coronavirus (SARS-CoV-2/COVID-19)

The Food and Drug Administration reminded clinical laboratory staff and health care providers to follow recommended steps to prevent false positive results from antigen tests for the COVID-19 virus, citing reports of false positives in nursing homes and other settings.
The Centers for Disease Control and Prevention would like to partner with one or more organizations to enable centralized reporting from COVID-19 testing entities to public health departments, the agency said this week in a request for information.
The Kansas Hospital Association launched an initiative with several ways for people to show appreciation to health care heroes during the pandemic.
German biotech firm CureVac N.V. announced interim data from its ongoing Phase 1 dose-escalation study evaluating its CVnCoV SARS-CoV-2 vaccine candidate for safety, reactogenicity and immunogenicity.
COVID-19 may be stifling normal operations around the country, but it isn’t stopping targeted innovation efforts with strong ROI potential to cut care delivery costs. In fact, 15 of 20 prominent health systems recently surveyed are actively pursuing commercial relationships with health tech…
With the daily count of COVID-19 diagnoses spiking nationally and some hospitals experiencing surge levels not seen since the spring, and with flu season upon us, an important question looms: Will health care’s global supply chain be able to meet the demand for personal protective equipment (PPE)…
AHA President and CEO Rick Pollack recently spoke with Modern Healthcare about a host of issues, including COVID-19, the future of the Affordable Care Act and the importance of preserving coverage, and what issues are at stake for hospitals and health systems during a lame-duck session of Congress.
The departments of Health and Human Services and Defense this weekend announced a pair of contracts to expand domestic COVID-19 testing capacity.
The AHA urged the Centers for Medicare & Medicaid Services to immediately withdraw the new condition of participation that threatens to expel hospitals from the Medicare program if they fail to comply with “frequently changing and confusing” COVID-19 data collection efforts.